Form 8-K - Current report:
SEC Accession No. 0001193125-23-086943
Filing Date
2023-03-31
Accepted
2023-03-31 09:02:54
Documents
12
Period of Report
2023-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d488380d8k.htm   iXBRL 8-K 25152
  Complete submission text file 0001193125-23-086943.txt   150973

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrn-20230327.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20230327_lab.xml EX-101.LAB 18689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20230327_pre.xml EX-101.PRE 11692
6 EXTRACTED XBRL INSTANCE DOCUMENT d488380d8k_htm.xml XML 3940
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 23783565
SIC: 2834 Pharmaceutical Preparations